FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068409042> ?p ?o ?g. }

• W2068409042 endingPage "322" @default.
• W2068409042 startingPage "313" @default.
• W2068409042 abstract "Gaucher disease type 1, the most prevalent lysosomal storage disease, is caused by the defective activity of the lysosomal enzyme, acidβ-glucosidase, or glucocerebrosidase. Infusion of purified acidβ-glucosidase containing α-mannosyl-terminated oligosaccharides(alglucerase) is efficacious in reversing hematologic, hepatic, splenic, and bony disease manifestations. The murine tissue distribution and turnover of bolus injections of alglucerase was evaluated by enzymatic activity, quantitative cross-reacting immunologic material analyses, and immunofluorescence studies. Enzyme activity measurements detected distribution to liver, spleen, thymus, kidney, and bone marrow mononuclear cells, but not to lungs and brain. In kidney and thymus, the enzyme was transiently present. In liver and spleen, enzyme activity peaked at about 20 min postinjection followed by a biphasic decrease with t½ ≈ 40-60 min and≈ 12-14 h. In bone marrow maximal enzyme activity was at 40-60 min with a disappearance t½ ≈ 60 min. Quantitative cross-reacting immunologic material studies of liver and spleen showed delivery of enzyme with decreased catalytic rate constants whose degradation included denaturation and proteolytic components. By immunofluorescence the human enzyme was distributed primarily to reticuloendothelial cells of the liver and spleen. In autopsy material from a Gaucher disease type 2 patient treated with enzyme, immunohistochemical and activity studies showed distributions similar to those in mice. These studies indicate a complex delivery and intracellular degradation of acid β-glucosidase with lower intrinsic activity than the administered therapeutic agent." @default.
• W2068409042 created "2016-06-24" @default.
• W2068409042 creator A5002548410 @default.
• W2068409042 creator A5023640583 @default.
• W2068409042 creator A5038025364 @default.
• W2068409042 creator A5042864917 @default.
• W2068409042 creator A5044949060 @default.
• W2068409042 creator A5057590021 @default.
• W2068409042 creator A5077759846 @default.
• W2068409042 date "1996-02-01" @default.
• W2068409042 modified "2023-09-27" @default.
• W2068409042 title "Turnover and Distribution of Intravenously Administered Mannose-Terminated Human Acid β-Glucosidase in Murine and Human Tissues" @default.
• W2068409042 cites W1493970508 @default.
• W2068409042 cites W1502124563 @default.
• W2068409042 cites W1525577371 @default.
• W2068409042 cites W1534327410 @default.
• W2068409042 cites W1775749144 @default.
• W2068409042 cites W1978105709 @default.
• W2068409042 cites W1991348330 @default.
• W2068409042 cites W1998222693 @default.
• W2068409042 cites W2007153121 @default.
• W2068409042 cites W2010593593 @default.
• W2068409042 cites W2018603101 @default.
• W2068409042 cites W2021832357 @default.
• W2068409042 cites W2051901707 @default.
• W2068409042 cites W2060595330 @default.
• W2068409042 cites W2061700574 @default.
• W2068409042 cites W2076311962 @default.
• W2068409042 cites W2076780197 @default.
• W2068409042 cites W2086192707 @default.
• W2068409042 cites W2094360785 @default.
• W2068409042 cites W2104395201 @default.
• W2068409042 cites W2169062484 @default.
• W2068409042 cites W2171928896 @default.
• W2068409042 cites W2256622923 @default.
• W2068409042 cites W230215977 @default.
• W2068409042 cites W2316964369 @default.
• W2068409042 cites W2322128806 @default.
• W2068409042 cites W2326229951 @default.
• W2068409042 doi "https://doi.org/10.1203/00006450-199602000-00021" @default.
• W2068409042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8825806" @default.
• W2068409042 hasPublicationYear "1996" @default.
• W2068409042 type Work @default.
• W2068409042 sameAs 2068409042 @default.
• W2068409042 citedByCount "55" @default.
• W2068409042 countsByYear W20684090422012 @default.
• W2068409042 countsByYear W20684090422013 @default.
• W2068409042 countsByYear W20684090422014 @default.
• W2068409042 countsByYear W20684090422017 @default.
• W2068409042 countsByYear W20684090422018 @default.
• W2068409042 countsByYear W20684090422019 @default.
• W2068409042 countsByYear W20684090422020 @default.
• W2068409042 countsByYear W20684090422021 @default.
• W2068409042 countsByYear W20684090422022 @default.
• W2068409042 countsByYear W20684090422023 @default.
• W2068409042 crossrefType "journal-article" @default.
• W2068409042 hasAuthorship W2068409042A5002548410 @default.
• W2068409042 hasAuthorship W2068409042A5023640583 @default.
• W2068409042 hasAuthorship W2068409042A5038025364 @default.
• W2068409042 hasAuthorship W2068409042A5042864917 @default.
• W2068409042 hasAuthorship W2068409042A5044949060 @default.
• W2068409042 hasAuthorship W2068409042A5057590021 @default.
• W2068409042 hasAuthorship W2068409042A5077759846 @default.
• W2068409042 hasBestOaLocation W20684090421 @default.
• W2068409042 hasConcept C134018914 @default.
• W2068409042 hasConcept C159654299 @default.
• W2068409042 hasConcept C181199279 @default.
• W2068409042 hasConcept C185592680 @default.
• W2068409042 hasConcept C19702531 @default.
• W2068409042 hasConcept C203014093 @default.
• W2068409042 hasConcept C2778236600 @default.
• W2068409042 hasConcept C2780007613 @default.
• W2068409042 hasConcept C2780091579 @default.
• W2068409042 hasConcept C2780674200 @default.
• W2068409042 hasConcept C2780931953 @default.
• W2068409042 hasConcept C28212737 @default.
• W2068409042 hasConcept C55493867 @default.
• W2068409042 hasConcept C86803240 @default.
• W2068409042 hasConceptScore W2068409042C134018914 @default.
• W2068409042 hasConceptScore W2068409042C159654299 @default.
• W2068409042 hasConceptScore W2068409042C181199279 @default.
• W2068409042 hasConceptScore W2068409042C185592680 @default.
• W2068409042 hasConceptScore W2068409042C19702531 @default.
• W2068409042 hasConceptScore W2068409042C203014093 @default.
• W2068409042 hasConceptScore W2068409042C2778236600 @default.
• W2068409042 hasConceptScore W2068409042C2780007613 @default.
• W2068409042 hasConceptScore W2068409042C2780091579 @default.
• W2068409042 hasConceptScore W2068409042C2780674200 @default.
• W2068409042 hasConceptScore W2068409042C2780931953 @default.
• W2068409042 hasConceptScore W2068409042C28212737 @default.
• W2068409042 hasConceptScore W2068409042C55493867 @default.
• W2068409042 hasConceptScore W2068409042C86803240 @default.
• W2068409042 hasIssue "2" @default.
• W2068409042 hasLocation W20684090421 @default.
• W2068409042 hasLocation W20684090422 @default.
• W2068409042 hasOpenAccess W2068409042 @default.
• W2068409042 hasPrimaryLocation W20684090421 @default.
• W2068409042 hasRelatedWork W114454170 @default.

• next